MABEXPRESS
Live / Registered — Registered (as of 06 May 2025)
What this means for you
Registered since 06 May 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98050400
- Registration number
- 7782068
- Mark type
- Stylized text
- Filed
- 20 Jun 2023
- Published for opposition
- 18 Mar 2025
- Registered
- 06 May 2025
- Attorney of record
- William C. Wright
Goods and services
- Class 040 — Treatment of materials: Custom manufacture of biopharmaceuticals; consultancy relating to biopharmaceutical manufacturing; consultancy relating to the manufacturing of therapeutics; custom biopharmaceutical drug manufacturing services
- Class 042 — Scientific and technological services: Scientific laboratory services relating to the production of monoclonal antibodies; product development services in the nature of biodevelopment services relating to the production of monoclonal antibodies; consultancy relating to biopharmaceutical research and development; biopharmaceutical drug development services; conducting of quality control tests for others; quality control services for others; quality assurance services in the field of biopharmaceuticals; testing, analysis and validation of biopharmaceuticals related to the development and production of monoclonal antibodies; research and development of therapeutics and consultancy related thereto
Owner
- Merck KGaA, 64293 Darmstadt, DE
- Merck KGaA, 64293 Darmstadt, DE
- Merck KGaA, 64293 Darmstadt, DE
Prosecution history
- 06 May 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 May 2025 — REGISTERED-PRINCIPAL REGISTER
- 18 Mar 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 18 Mar 2025 — PUBLISHED FOR OPPOSITION
- 12 Mar 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 28 Jan 2025 — PUBLISHED FOR OPPOSITION
- 22 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 Jan 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Sept 2024 — ASSIGNED TO LIE
- 15 Apr 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Jan 2024 — NON-FINAL ACTION E-MAILED